{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:21:53Z","timestamp":1792142513879,"version":"4.4.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2017,7,4]]},"DOI":"10.1001\/jama.2017.7117","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T12:36:49Z","timestamp":1499085409000},"page":"45","source":"Crossref","is-referenced-by-count":207,"title":["Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes"],"prefix":"10.1001","volume":"318","author":[{"given":"Carol","family":"Wysham","sequence":"first","affiliation":[{"name":"Rockwood Clinic, University of Washington School of Medicine, Spokane"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Bhargava","sequence":"additional","affiliation":[{"name":"Iowa Diabetes and Endocrinology Research Center, Des Moines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Chaykin","sequence":"additional","affiliation":[{"name":"Meridien Research, Bradenton, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"de la Rosa","sequence":"additional","affiliation":[{"name":"Paducah Endocrinology, Paducah, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Handelsman","sequence":"additional","affiliation":[{"name":"Metabolic Institute of America, Tarzana, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone N.","family":"Troelsen","sequence":"additional","affiliation":[{"name":"Medical and Science, Novo Nordisk, S\u00f8borg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajsa","family":"Kvist","sequence":"additional","affiliation":[{"name":"Biostatistics Insulin and Diabetes Outcomes, Novo Nordisk, S\u00f8borg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Norwood","sequence":"additional","affiliation":[{"name":"Valley Research, Fresno, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jama.jamanetwork.com\/ama\/content_public\/journal\/jama\/936346\/jama_wysham_2017_oi_170059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:11:57Z","timestamp":1683303117000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2017.7117"}},"subtitle":["The SWITCH 2 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2017,7,4]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2017.7117","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7,4]]}}}